Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuits
Ryan A. DenuiD, Veena KochatiD, Zhao Zheng, Suresh SatpatiiD, Danh D. TruongiD, Emre ArslaniD, Corey WeistuchiD, Margarita DivenkoiD, Manrong WuiD, William I. Padron, Davis R IngramiD, Khalida WaniiD, Wei-Lien WangiD, Sharon M. LandersiD, Hannah C. BeirdiD, Jamie L McCuistoniD, Alysha SimmonsiD, Liz Marie Albertorio-SáeziD, Danielle N MaryanskiiD, Cheryl C SzanyiD, Bryan J. VentersiD, Carolina P. LiniD, Michael‐Christopher KeoghiD, Keila E. TorresiD, Christina Lynn RolandiD, , Kunal RaiiD
Abstract
Well-differentiated and dedifferentiated liposarcoma (WDLPS and DDLPS) exhibit markedly different clinical behaviors, with DDLPS showing greater aggressiveness, higher recurrence and metastasis rates, and worse outcomes. Using single-nucleus multiome sequencing, epigenomic profiling, and spatial transcriptomics, we characterized cellular and epigenetic heterogeneity between these subtypes at single-cell and spatial resolution. We found distinct phenotypic states reflecting altered lineage differentiation and plasticity: DDLPS is dominated by early-differentiated progenitor-like cells, sclerotic WDLPS displays broader mesenchymal lineage plasticity, and adipocytic WDLPS contains abundant committed adipocytes. The DDLPS immune microenvironment was dominated by immunosuppressive macrophages, whereas WDLPS harbored more T cells and inflammatory macrophages. Notably, sclerotic WDLPS displayed intermediate cellular and molecular features, suggesting it may represent a distinct WDLPS subtype. Importantly, we identified novel gene regulatory circuits underlying each state, including FABP4/PPARG programs in adipocytic WDLPS, GLI2/TCF7L2/RBPJ/KLF7 programs in sclerotic WDLPS, and KLF7/FOSL2/SP3/GLI2/RBPJ programs in DDLPS. H3K27ac-marked enhancers were enriched near adipocytic marker genes in WDLPS and mesenchymal markers in DDLPS. Together, these findings reveal the cellular heterogeneity of tumor and immune compartments across liposarcoma subtypes and identify regulatory programs driving their differentiation states. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=155 SRC="FIGDIR/small/713651v1_ufig1.gif" ALT="Figure 1"> View larger version (73K): org.highwire.dtl.DTLVardef@1c84ee1org.highwire.dtl.DTLVardef@1b2ad42org.highwire.dtl.DTLVardef@18ce5a6org.highwire.dtl.DTLVardef@138f615_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity
Erica Maria Pimenta, Amanda Garza, … Eliezer M. Van Allen·Science Translational MedicinePeer-reviewed·Jan 21, 2026
- PPARG governs adipogenic differentiation and cell state plasticity in well-differentiated and dedifferentiated liposarcoma
Blake R. Wilde, Kyle D. Klingbeil, … Heather R. Christofk·Science AdvancesPeer-reviewed·Jul 31, 2026
- Gli2 Overexpression Alters the Differentiation Status of Dedifferentiated Liposarcoma Cells and Results in an Immunosuppressive Myeloid Phenotype in Orthotopic Tumors
Natalie E. Bennett, Erik P. Beadle, … Julie A. Rhoades·bioRxiv·Sep 18, 2024
- Immunocompetent murine models recapitulate the heterogeneous tumor immune microenvironment of human liposarcoma
Amanda M. Shafer, Emma Kenna, … Christina Vadala Angeles·Clinical Cancer ResearchPeer-reviewed·Sep 10, 2025
- A CRISPR-based Xenopus tropicalis model for retroperitoneal liposarcoma with genetic control over the dedifferentiation process
Marthe Boelens, Dieter Tulkens, … Kris Vleminckx·bioRxiv·Mar 30, 2026
- Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A. Denu, Zhao Zheng, … Kunal Rai·bioRxiv·May 26, 2026